Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024
Compare Balance Sheet Results of Vista Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
12.31
7.55
4.76
63.05%
Share Warrants & Outstandings
Total Reserve
33.10
25.58
7.52
29.40%
Shareholder's Funds
45.42
33.13
12.29
37.10%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.38
2.57
-0.19
-7.39%
Secured Loans
2.38
1.23
1.15
93.50%
Unsecured Loans
0.00
1.33
-1.33
-100.00%
Deferred Tax Assets / Liabilities
-4.37
-0.17
-4.20
-2,470.59%
Other Long Term Liabilities
0.00
0.03
-0.03
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.12
0.00
0.12
0.00%
Total Non-Current Liabilities
-1.87
2.42
-4.29
-177.27%
Current Liabilities
Trade Payables
5.59
31.89
-26.30
-82.47%
Other Current Liabilities
1.74
12.66
-10.92
-86.26%
Short Term Borrowings
5.02
13.94
-8.92
-63.99%
Short Term Provisions
0.01
0.00
0.01
0.00%
Total Current Liabilities
12.37
58.48
-46.11
-78.85%
Total Liabilities
55.92
94.03
-38.11
-40.53%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.18
5.17
22.01
425.73%
Less: Accumulated Depreciation
8.48
2.55
5.93
232.55%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
18.70
2.62
16.08
613.74%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
10.14
0.00
10.14
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.05
0.00
0.05
0.00%
Long Term Loans & Advances
2.12
0.00
2.12
0.00%
Other Non Current Assets
0.00
3.74
-3.74
-100.00%
Total Non-Current Assets
31.01
6.36
24.65
387.58%
Current Assets Loans & Advances
Current Investments
0.00
1.67
-1.67
-100.00%
Inventories
8.22
4.67
3.55
76.02%
Sundry Debtors
13.54
54.62
-41.08
-75.21%
Cash and Bank
0.73
3.11
-2.38
-76.53%
Other Current Assets
0.41
2.06
-1.65
-80.10%
Short Term Loans and Advances
2.00
21.55
-19.55
-90.72%
Total Current Assets
24.91
87.67
-62.76
-71.59%
Net Current Assets (Including Current Investments)
12.54
29.19
-16.65
-57.04%
Total Current Assets Excluding Current Investments
24.91
86.00
-61.09
-71.03%
Miscellaneous Expenses not written off
0.00
0.22
-0.22
-100.00%
Total Assets
55.92
94.03
-38.11
-40.53%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.40
16.51
-9.11
-55.18%
Book Value per share (adjusted)
7.38
43.90
-36.52
-83.19%
Annual - Borrowings
Borrowings 7.40 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 28.84 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Annual - Investments
Investments 0.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Annual - Current Assets
Current Assets 24.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024
Footer loading
